SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-228037
Filing Date
2015-06-19
Accepted
2015-06-19 09:05:01
Documents
10
Period of Report
2015-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d947400d8k.htm 8-K 24812
2 EX-1.1 d947400dex11.htm EX-1.1 174062
3 EX-4.1 d947400dex41.htm EX-4.1 85933
4 EX-4.2 d947400dex42.htm EX-4.2 19066
5 EX-5.1 d947400dex51.htm EX-5.1 16095
6 EX-99.1 d947400dex991.htm EX-99.1 10671
7 EX-99.2 d947400dex992.htm EX-99.2 11624
8 GRAPHIC g947400ex5_1logo.jpg GRAPHIC 11535
9 GRAPHIC g947400ex99_1logo.jpg GRAPHIC 11332
10 GRAPHIC g947400ex99_2logo.jpg GRAPHIC 11332
  Complete submission text file 0001193125-15-228037.txt   391335
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 15941476
SIC: 2834 Pharmaceutical Preparations